ValuEngine upgraded shares of Sysmex (OTCMKTS:SSMXY) from a hold rating to a buy rating in a research report report published on Monday morning.

Sysmex stock opened at $44.25 on Monday. The stock has a market cap of $17.83 billion, a PE ratio of 53.49 and a beta of -0.75. Sysmex has a 1 year low of $27.18 and a 1 year high of $46.57.

Sysmex Company Profile

Sysmex Corporation, together with its subsidiaries, engages in the development, manufacture, sale, and export/import of diagnostic instruments, reagents, and related software for the use in hematology, urinalysis, immunochemistry, clinical chemistry, and hemostasis worldwide. It offers three-part and five-part white blood cell differentiation instruments for use in hematology; systems for high-volume testing in labs; and hematology analyzers for animals.

To view ValuEngine’s full report, visit ValuEngine’s official website.

Receive News & Ratings for Sysmex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sysmex and related companies with's FREE daily email newsletter.